Boston Scientific Corp.

( )
BSX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. -2.19%596.431.0%$848.62m
DHRDanaher Corp. -2.62%315.990.7%$645.23m
ABTAbbott Laboratories -3.01%120.630.8%$543.05m
ISRGIntuitive Surgical, Inc. -2.84%1013.752.3%$524.35m
MDTMedtronic Plc -0.94%128.800.6%$447.96m
BDXBecton, Dickinson & Co. -0.66%251.511.0%$354.37m
ALGNAlign Technology, Inc. -3.34%701.046.3%$335.38m
BAXBaxter International, Inc. -0.40%80.531.8%$319.34m
HRCHill-Rom Holdings, Inc. -0.45%149.322.2%$318.98m
IDXXIDEXX Laboratories, Inc. -4.36%650.023.8%$307.49m
DXCMDexCom, Inc. -2.08%549.077.8%$296.17m
SYKStryker Corp. -1.18%273.371.3%$275.51m
BSXBoston Scientific Corp. -0.52%44.471.0%$263.43m
ZBHZimmer Biomet Holdings, Inc. 0.25%151.611.7%$246.01m
AAgilent Technologies, Inc. -3.38%166.571.6%$225.36m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.